PPT-Diabetic dyslipidemia : The pro-

Author : deborah | Published Date : 2022-06-28

atherogenic role of CETP and future use of CETP inhibitors Prof John Betteridge University College London United Kingdom Diabetes and Cardiovascular Disease Time

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Diabetic dyslipidemia : The pro-" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Diabetic dyslipidemia : The pro-: Transcript


atherogenic role of CETP and future use of CETP inhibitors Prof John Betteridge University College London United Kingdom Diabetes and Cardiovascular Disease Time To Act With the rising tide of diabetes around the globe the double jeopardy of diabetes and cardiovascular disease is set to result in an explosion of these and other complications unless preventive action is taken. Emergencies. . . Dr.Hicham. Al . Mawla. . Class . Outline . •Diabetic emergency/. Glucometer. training . •Identify the different signs of insulin shock . •Diabetic coma, and HHNK . Eye Screening Service. Stephanie Holland, Service Manager and Dr Philip Haynes, GP Brookside Practice. Aims:. To reduce the risk of sight loss amongst people with diabetes by a systematic screening programme for diabetic retinopathy that fully complies with the national standards set by the NHS Diabetic Eye Screening Programme (NHS DESP).. Eye Screening Service. Stephanie Holland, Service Manager and Dr Philip Haynes, GP Brookside Practice. Aims:. To reduce the risk of sight loss amongst people with diabetes by a systematic screening programme for diabetic retinopathy that fully complies with the national standards set by the NHS Diabetic Eye Screening Programme (NHS DESP).. (DR) . Ayesha S Abdullah. 03.01.2014. Learning outcomes. By . the end of the lecture the students would be able . to;. Describe the epidemiology of DR. Correlate the pathogenesis of DR with the clinical . Ayesha S Abdullah. 28.12.2012. Learning outcomes. By . the end of the lecture the students would be able . to;. Describe the epidemiology of DR. Correlate the pathogenesis of DR with the clinical . presentation . 2013 ACC/AHA Guideline on the. Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. IMPROVE-IT. 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia. A program of the National Institutes of HealthYou Should KnowAbout Diabetic or even blindness To help you keep your vision healthy here are x00660069ve things the National Eye A group of eye problems1 /Lipid management in . Diabetes. Dr.Zahra. . davoudi. Endocrinology department of . Loghman. Hakim Hospital, . Shahid. . Beheshti. University of Medical Sciences. A . 65 year-old woman . with medical history of . What is diabetes?Disorder of carbohydrate metabolismLack of effect or production of endogenous insulinType 1 and Type 2Multiple organ involvement Organs affectedLarge blood vessel disease HeartNerv Clinics (www.dhs.state.mn.us) ProcedureRisk AssessmentThe following are examples of recommended risk factors that can be identified through the personal and family health history and physical measurem Rodica. Pop-. Busui. , M.D., . Ph.D. Division of Metabolism, Endocrinology and Diabetes. Michigan Comprehensive Diabetes Center. University of . Michigan. Diabetes is the dominant cause of ESRD in USA. . Shahin. . Nosratzehi. . volume . 14 | JUNE 2018 | . 361. Agenda. Introduction. Classical phenotype. Mechanisms of . DKD. Immediate effects of . hyperglycemia. Late effects of . hyperglycemia. Non-protein uric phenotype. Dathan M. Byonanebye, Mark N. Polizzotto, Fernando Maltez, Andri Rauch, Katharina Grabmeier-Pfistershammer, Ferdinand Wit, Stéphane De Wit, Antonella Castagna, Antonella . D’Arminio. Monforte, Cristina Mussini, Jan-Christian Wasmuth, Eric . Lipidology. and Atherosclerosis (KSLA). . Hyper-LDL-. cholesterolemia. . LDL-cholesterol (LDL-. C. ) . ≥160 mg/. dL. . . or . use of lipid-lowering medication .

Download Document

Here is the link to download the presentation.
"Diabetic dyslipidemia : The pro-"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents